Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of hazardous materials"
DOI: 10.1016/j.jhazmat.2020.124757
Abstract: By using a thiophene-containing triazole ligand -3,5-di(thiophen-2-yl)-1H-1,2,4-triazole (3,5-Th2-tzH) and 3,5-diphenyl-1H-1,2,4-triazole (3,5-Ph2-tzH) in different molar ratio in the reactant, copper(I) mixed-triazolate frameworks CuMtz-1 {[Cu8(3,5-Ph2-tz)6-x(3,5-Th2-tz)x](BF4)2(CH3OH)3} (x = 0.5 for CuMtz-1a and 1.1 for CuMtz-1b) were firstly synthesized and characterized…
read more here.
Keywords:
copper mixed;
mixed triazolate;
triazolate frameworks;
thiophene ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Polyhedron"
DOI: 10.1016/j.poly.2020.114753
Abstract: Abstract Cu(II) mixed-ligand complexes of the type [Cu(ofx)(bipym)(CH3OH)].ClO4·H2O and [Cu(cpx)(bipym)(NO3)].NO3·2H2O, where ofx = ofloxacin ([9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid]), cpx = ciprofloxacin ([1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinoline carboxylic acid hydrochloride]) and bipym = 2,2′-bipyridylamine, have been synthesized and characterized by elemental analysis, spectroscopic techniques (UV–Vis and FTIR), electron spin…
read more here.
Keywords:
ligand complexes;
copper mixed;
analysis;
complexes fluoroquinolones ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15041314
Abstract: The effects of two anticancer active copper(II) mixed-ligand complexes of the type [Cu(qui)(mphen)]Y·H2O, where Hqui = 2-phenyl-3-hydroxy- 1H-quinolin-4-one, mphen = bathophenanthroline, and Y = NO3 (complex 1) or BF4 (complex 2) on the activities of…
read more here.
Keywords:
copper mixed;
ic50 values;
pharmacokinetic properties;
mixed ligand ... See more keywords